ModernMedicine Resource Center More Topics

Video

Doctor Preparation for Overactive Bladder Patients

Caroline Rhea and Dr. Elizabeth R. Mueller speak about the steps Doctors can take to identify and help OAB patients.

OAB and IC, BPS Resource Center

New Products: App helps moviegoers with OAB, new mesh for sacrocolpopexy, and moreIn this round-up of new urology products and services, learn about an app that helps moviegoers with OAB, a new mesh for sacrocolpopexy, and device/smartphone app that help women with pelvic floor exercises.
Overactive bladder: Two drugs found better than one
Overactive bladder: Two drugs found better than oneA two-drug treatment regimen works better than monotherapy for incontinent overactive bladder patients, researchers reported at the AUA annual meeting in New Orleans.
New Products: Compounded formulations for IC, ED and moreOther products featured include: Radiosurgery collimator allows treatment of broad rang of tumors and Phi prostate cancer test and more.
IC/BPS: Agent brings glimmer of hope
IC/BPS: Agent brings glimmer of hopeFor the desperate patient with severe symptoms and a contracted, inflamed bladder who has failed standard therapies, cyclosporine A can be an effective treatment and prevent or delay the need for cystectomy and/or urinary diversion.
Cyclosporine A found efficacious for refractory IC
Cyclosporine A found efficacious for refractory ICLong-term cyclosporine A therapy may be an effective treatment option for refractory interstitial cystitis, say researchers from Brazil.
Coverage for OAB nerve stim device expands
Coverage for OAB nerve stim device expandsUroplasty, Inc. announced that Cigna has written a positive coverage policy for percutaneous tibial nerve stimulation delivered via Uroplasty's Urgent PC neuromodulation system for treatment of overactive bladder and associated symptoms of urinary urgency, urinary frequency, and urge incontinence.
Anticholinergic cycling not effective in OAB with UI
Anticholinergic cycling not effective in OAB with UIThe adage, “If at first you don’t succeed, try, try again,” does not appear to hold true when it comes to anticholinergic drug use in overactive bladder patients with urinary incontinence, recent study results indicate.
PTNS for overactive bladder: Patient selection and technique
PTNS for overactive bladder: Patient selection and techniqueThis article provides a real-world definition of refractory overactive bladder and its prevalence, then examines treatment options, with a focus on percutaneous tibial nerve stimulation as a noninvasive form of neuromodulation “for the masses.”
December 2014 New Products: Company acquires U.S. rights to interstitial cystitis formulationOther products discussed in this article include a prosthesis for underactive bladder, a prostate cancer test, and an erectile dysfunction drug.
‘Continued success’ seen with botulinum injections
‘Continued success’ seen with botulinum injectionsRepeated onabotulinumtoxinA 100 U (onabotA [Botox]) injections continue to provide benefit for patients with overactive bladder syndrome and urinary incontinence and without evidence of any new safety concerns, according to results of a pre-specified interim analysis in an open-label, 3-year extension study.